Tekla Capital Management teklacap.com

Tekla Capital Management, formerly Hambrecht & Quist Capital Management (HQCM), is a Boston, MA based healthcare-focused investment manager with approximately $2.3 billion of assets under management as of September 30, 2014. Tekla serves as investment adviser to three closed-end funds: Tekla Healthcare Investors, Tekla Life Sciences Investors and Tekla Healthcare Opportunities Fund. Tekla Healthcare Investors is a diversified closed-end healthcare fund that primarily invests in the healthcare i...Show all

Tekla Capital Management, formerly Hambrecht & Quist Capital Management (HQCM), is a Boston, MA based healthcare-focused investment manager with approximately $2.3 billion of assets under management as of September 30, 2014. Tekla serves as investmen...Show all

See All Exits Recent Exits

Phone: 617-772-8500

Fax:

2 Liberty Square
9th Floor
 Boston, 02109
 Massachusetts, United States

Tekla Capital Management - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2018-05-09BioClin TherapeuticsSeries B - II$20MHealthCap Venture Capital, INKEF Capital, Life Sciences Partners, Sectoral Asset Management, Sofinnova Ventures, and Ysios Capital Partners
2017-07-25Milestone PharmaceuticalsSeries C$55MBDC Healthcare Venture Fund, Domain Associates, Fonds de Solidarite FTQ, Forbion Capital Partners, Go Capital, Novo A/S, and Pappas Ventures
2017-03-21BioClin TherapeuticsSeries B$30MHealthCap Venture Capital, Life Sciences Partners, Sofinnova Ventures, and Ysios Capital Partners
2015-08-26MerusSeries C$80.5MAglaia Biomedical Ventures, Bay City Capital, Johnson & Johnson Innovation, Life Sciences Partners, Novartis Venture Funds, Novo A/S, Pfizer Venture Investments, RA Capital Management, Rock Springs Capital, and Sofinnova Ventures
2015-08-11Ovid TherapeuticsSeries B$75MCormorant Asset Management, Cowen Private Investments, DoubleLine Equity Healthcare Fund, Fidelity Investments, Jennison Associates, Redmile Group, Sanofi-Genzyme BioVentures, and Sphera Funds
See all 5 investments